ERCC1 and nasopharyngeal carcinoma: In addition, in primary NPC, BRCA1– and ERCC1– patients had the highest response rate compared to patients that were BRCA1+ and ERCC1+, BRCA1– and ERCC1+ and BRCA1+ and ERCC1–, P=0.005.